Enhanced Robotically Controlled Clot Manipulation and Removal System

Publication ID: 24-11857277_0006_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Robotically Controlled Clot Manipulation and Removal System,” Published Technical Disclosure No. 24-11857277_0006_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857277_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,277.

Summary of the Inventive Concept

The inventive concept disclosed herein is directed to an improved medical system for robotically controlled clot manipulation and removal, offering enhanced imaging, guidance, and instrument articulation for more efficient and safe clot removal.

Background and Problem Solved

The original patent disclosed a robotically controlled system for removing clots from patients, but it had limitations in terms of imaging and guidance, articulation cable design, and instrument customization. The new inventive concept addresses these limitations by introducing advanced imaging and real-time feedback, modified instrument systems with improved articulation cables, and customizable distal tips.

Detailed Description of the Inventive Concept

The enhanced system comprises a robotic arm with a steerable endoscope and an integrated suction device, allowing for simultaneous visualization and removal of the clot. The instrument system features novel, adjustable distal tips that can be customized for different clot sizes and types. The system also includes real-time feedback to monitor clot removal and adjust the removal process accordingly. Additionally, the system can be equipped with high-resolution imaging devices to provide real-time visualization of the clot and surrounding tissue.

Novelty and Inventive Step

The new inventive concept introduces several novel features, including enhanced imaging and guidance, modified instrument systems with improved articulation cables, and customizable distal tips. These features provide a non-obvious improvement over the original patent, enabling more efficient, safe, and effective clot removal.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of imaging modalities, such as ultrasound or MRI, or incorporating additional sensors to provide real-time feedback. The system could also be adapted for use in different medical procedures, such as tumor removal or tissue biopsy.

Potential Commercial Applications and Market

The enhanced robotically controlled clot manipulation and removal system has significant commercial potential in the medical device industry, particularly in the areas of neurology, cardiology, and peripheral vascular disease treatment. The system's ability to provide more efficient and safe clot removal could lead to improved patient outcomes and reduced healthcare costs.

CPC Classifications

SectionClassGroup
A A61 A61B34/30
A A61 A61B17/12136
A A61 A61B17/3207
A A61 A61B2017/22038
A A61 A61B2034/301
A A61 A61B2034/303
A A61 A61B2090/08021

Field of Art

Medical device engineering, specifically robotic surgical systems for vascular intervention, focusing on minimally invasive clot removal technologies. Requires expertise in robotics, medical instrumentation, endovascular techniques, and advanced imaging systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional radiologist with advanced degrees, experience in robotic surgical design, understanding of vascular anatomy, and knowledge of medical device development and imaging technologies

Obviousness Rationale

A PHOSITA would recognize that the PTD's enhancements represent predictable variations of the source patent's core robotic clot removal technology. The disclosed improvements in imaging, articulation, and real-time feedback are logical extensions of existing robotic surgical principles. These modifications represent standard design iterations that would be apparent to a skilled practitioner seeking to optimize medical intervention technologies.

Obvious Combinations & Variations

Source Patent Element
Robotically controlled instrument system with elongate members and articulation cables
PTD Variation
Enhanced instrument system with improved articulation cables and customizable distal tips
Obviousness Reasoning
Modifying instrument geometry and tip configurations is a routine design optimization for medical devices, representing a predictable variation within known technological parameters
Source Patent Element
Basic clot removal system with multiple elongate members
PTD Variation
Integrated steerable endoscope with simultaneous suction and visualization capabilities
Obviousness Reasoning
Combining visualization and intervention tools is a known technique in minimally invasive surgical technologies, representing an obvious improvement for precision medical procedures
Source Patent Element
Robotic system for manipulating medical instruments
PTD Variation
Real-time feedback mechanisms for monitoring and adjusting clot removal process
Obviousness Reasoning
Implementing adaptive control systems is a standard engineering approach for improving medical device performance, utilizing well-established control theory principles
Source Patent Element
Basic instrument for clot manipulation
PTD Variation
High-resolution imaging integration for real-time tissue and clot visualization
Obviousness Reasoning
Incorporating advanced imaging technologies is a predictable enhancement in medical device design, representing a finite set of known improvement strategies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857277 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and lacking inventive step. The published technical disclosure demonstrates that the proposed enhancements represent routine design optimizations within the established technological framework of robotic vascular intervention systems, thereby rendering subsequent claims of novelty invalid under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,277
TitleRobotically controlled clot manipulation and removal
Assignee(s)Auris Health, Inc.